Skip to contentMammen Mathai — THERAVANCE INC insider: 107 transactions · InsiderLensMammen Mathai
- SVP, Research & Early Clin Dev at THERAVANCE INC · on record since May 22, 2009
- Director at Parabilis Medicines, Inc. · on record since Jun 9, 2026
- President & CEO at Parabilis Medicines, Inc. · on record since Jun 9, 2026
- SVP, Research & Development at Theravance Biopharma, Inc. · on record since Feb 24, 2015
- Director at 10x Genomics, Inc. · on record since Sep 16, 2019
- EVP, Pharm, R&D at JOHNSON & JOHNSON · on record since Feb 17, 2022
Insider trading activity of Mammen Mathai
- Transactions on record
- 107
- since Jan 31, 2008
- Open-market buys
- 0
- Open-market sells
- 13
- $4.7M
- Companies traded
- 4
- last filing Jun 13, 2024
Figures computed from official regulatory filings — methodology.
Companies where Mammen Mathai has traded
Track record of Mammen Mathai
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of Mammen Mathai
Co-insiders of Mammen Mathai
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
PASQUALONE FRANKTheravance Biopharma, Inc. +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 13, 2024 | Award | 8,649 | 0.00 USD | $0 | SEC |
| Jun 16, 2023 | AwardD | 4,661 | 0.00 USD | $0 | SEC |
| Jun 16, 2023 | Award | 1,865 | 0.00 USD | $0 | SEC |
| May 15, 2023 | Sell | -33,000 | 52.82 USD | $1.7M | SEC |
| May 15, 2023 | Exercise | 200,000 | 1.16 USD | $232K | SEC |
| May 15, 2023 | ExerciseD | -200,000 | 0.00 USD | $0 | SEC |
| Jun 17, 2022 | AwardD | 5,300 | 0.00 USD | $0 | SEC |
| Jun 17, 2022 | Award | 2,120 | 0.00 USD | $0 | SEC |
| Feb 17, 2022 | Other | -3,366 | 165.89 USD | $558.4K | SEC |
| Feb 17, 2022 | ExerciseD | -7,740 | 0.00 USD | $0 | SEC |
| Feb 17, 2022 | AwardD | 38,736 | 165.89 USD | $6.4M | SEC |
| Feb 17, 2022 | Exercise | 7,740 | 0.00 USD | $0 | SEC |
| Feb 17, 2022 | AwardD | 3,922 | 0.00 USD | $0 | SEC |
| Feb 15, 2022 | ExerciseD | -7,418 | 0.00 USD | $0 | SEC |
| Feb 15, 2022 | Exercise | 7,418 | 0.00 USD | $0 | SEC |
| Feb 15, 2022 | Other | -2,335 | 168.85 USD | $394.3K | SEC |
| Jun 15, 2021 | Award | 625 | 0.00 USD | $0 | SEC |
| Jun 15, 2021 | AwardD | 1,563 | 0.00 USD | $0 | SEC |
| Jun 17, 2020 | AwardD | 4,432 | 0.00 USD | $0 | SEC |
| Sep 16, 2019 | OtherD | -200,000 | 0.00 USD | $0 | SEC |
| Sep 16, 2019 | OtherD | 200,000 | 0.00 USD | $0 | SEC |
| Mar 17, 2016 | Award | 90,000 | 0.00 USD | $0 | SEC |
| Feb 23, 2016 | Other | -19,844 | 15.65 USD | $310.6K | SEC |
| Nov 24, 2015 | Other | -934 | 17.17 USD | $16K | SEC |
| Aug 24, 2015 | Other | -934 | 12.98 USD | $12.1K | SEC |